Mangosteen ethanol extract alleviated the severity of collagen-induced arthritis in rats and produced synergistic effects with methotrexate
Open Access
- 4 December 2018
- journal article
- research article
- Published by Informa UK Limited in Pharmaceutical Biology
- Vol. 56 (1), 455-464
- https://doi.org/10.1080/13880209.2018.1506939
Abstract
Context: Garcinia mangostana Linn. (Guttiferae) pericarp is used as a traditional medicine in South Asia to treat inflammatory diseases. Objective: This study investigates therapeutic effects of G. mangostana pericarp ethanol extract (MAN) on collagen-induced arthritis (CIA) and interactions with methotrexate in vivo. Materials and methods: Male Sprague-Dawley rats with CIA were treated with MAN (0.5 g/kg/day), methotrexate (0.5 mg/kg, bw) or combination of both for 36 days, respectively (n=8/group). Another eight healthy and CIA rats served as normal and model control, respectively. Therapeutic effects were evaluated based on paw edema and arthritis score during the experiment and serological markers at the end of the study period. Histological and radiological examinations were used to assess joint destructions. The immune status was investigated by immunohistochemistry and flow cytometry. Results: All treatments decreased the arthritis score and paw inflammation in CIA rats. Combination regimen significantly reduced anti-cyclic citrullinated peptide antibody in CIA rats to 85.83% (p < 0.05) and notably alleviated synovial hyperplasia and cartilage degradation in joints. Different from methotrexate, MAN significantly augmented CD25(+) cells distribution (from 2.72 to 3.35%) and IL-10 secretion (from 202.4 to 241.2 pg/mL) in CIA rat blood. Meanwhile, MAN induced a greater IL-17 decrease and a FOXP3 increase in immune organs than MTX. Reduced TLR4 and IL-17 expression and elevated FOXP3 expression in joints also occurred under MAN treatment. Conclusions: MAN protected joints from destruction in CIA rats and exerted synergistic effects with methotrexate by improving immune microenvironment. The combination regimen could bring additional benefits to rheumatoid arthritis patients.Keywords
Funding Information
- National Natural Science Foundation of China
- State Administration of Traditional Chinese Medicine (-32)
- Natural Science Foundation of Anhui Province (09, zy37)
This publication has 31 references indexed in Scilit:
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- Pharmacokinetics of α‐mangostin in rats after intravenous and oral applicationMolecular Nutrition & Food Research, 2011
- Relationship Between Rheumatoid Factor Isotypes and IgG Anti-Cyclic Citrullinated Peptide AntibodiesThe Journal of Rheumatology, 2010
- The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritisNature Reviews Rheumatology, 2009
- Xanthones from the Seeds ofAllanblackia monticolaand Their Apoptotic and Antiproliferative ActivitiesPlanta Medica, 2008
- Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritisJCI Insight, 2008
- Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in ratsToxicology and Applied Pharmacology, 2005
- Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2005
- CD25+ cell depletion hastens the onset of severe disease in collagen‐induced arthritisArthritis & Rheumatism, 2003
- Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis: Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expressionArthritis & Rheumatism, 1990